Results 61 to 70 of about 9,892 (240)

Hyponatremia revisited: Translating physiology to practice [PDF]

, 2008
The complexity of hyponatremia as a clinical problem is likely caused by the opposite scenarios that accompany this electrolyte disorder regarding pathophysiology (depletional versus dilutional hyponatremia, high versus low vasopressin levels) and ...
Adrogue HJ, Anderson RJ, Aw TC, Bankir L, Beukhof CM, Bourque CW, Burbach JP, Carlotti AP, Chou CL, Chow KM, Chung HM, Decaux G, Decaux G, Decaux G, Decaux G, Detmers FJ, Diederich S, Dzau VJ, Ellison DH, Ewout J. Hoorn, Friedman E, Gagnon RF, Ghorbel MT, Goldberg A, Halperin ML, Hamburger S, Hoorn EJ, Hoorn EJ, Hoorn EJ, Hoorn EJ, Hsu YJ, Knochel JP, Kurotani R, Liamis G, Lohr JW, Londono MC, Maesaka JK, Maesaka JK, McGee S, McKinley MJ, Moritz ML, Musch W, Nielsen S, Noakes TD, Oliet SH, Papanicolaou DA, Patel GP, Porcel A, Reynolds RM, Robert Zietse, Robertson GL, Schrier RW, Schrier RW, Schrier RW, Shafiee MA, Siegel AJ, Smith JC, Sonnenblick M, Thaler SM, Turchin A, Umenishi F, Verbalis JG, Warner MH   +62 more
core   +2 more sources

A review of the molecular mechanisms underlying the development and progression of cardiac remodeling [PDF]

, 2017
Pathological molecular mechanisms involved in myocardial remodeling contribute to alter the existing structure of the heart, leading to cardiac dysfunction.
et al,, Yee, Derek
core   +7 more sources

Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4

Kidney International Reports, 2017
In the randomized placebo-controlled Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes (TEMPO) 3:4 trial, tolvaptan slowed kidney growth and renal function decline in subjects with autosomal ...
Olivier Devuyst, Arlene B. Chapman, Susan E. Shoaf, Frank S. Czerwiec, Jaime D. Blais   +4 more
doaj   +1 more source

Management of Pain in Autosomal Dominant Polycystic Kidney Disease and Anatomy of Renal Innervation [PDF]

, 2015
Purpose Chronic pain is a prominent feature of autosomal dominant polycystic kidney disease that is difficult to treat and manage, often resulting in a decrease in quality of life.
Bacallao, Robert L., Bahler, Clinton D., Shumate, Ashley M., Sundaram, Chandru P., Tellman, Matthew W.   +4 more
core   +1 more source

The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial [PDF]

, 2021
Judith E. Heida, Ron T. Gansevoort, Vicente E. Torres, Olivier Devuyst, Ronald D. Perrone, Jennifer Lee, Hui Li, John Ouyang, Arlene B. Chapman   +8 more
openalex   +1 more source

Severe Hyponatremia in the Emergency Department Incidence of Cerebral Edema and Risk of Osmotic Demyelination Syndrome

Academic Emergency Medicine, Volume 33, Issue 1, January 2026.
ABSTRACT Study Objective Treatment strategies in severe hyponatremia aim at rapid sodium correction to prevent or treat cerebral edema but limit sodium rise to prevent osmotic demyelination syndrome (ODS). The true risk of edema or ODS in ED patients is unknown.
Volker Burst, Ramon Rabii, Julian Peto‐Madew, Thorsten Persigehl, Stefan Haneder, Matthias Johannes Hackl, Christoph Hüser, Moritz Trappe, Sadrija Cukoski, Kathrin Möllenhoff, Victor Suárez   +10 more
wiley   +1 more source

Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
The graphical abstract for the stability of medicatioins administred via enteral feeding tube: A systematic review ((PROSPERO, registration number: CRD42024580820)). ABSTRACT Feeding tubes are essential for patients unable to maintain adequate oral intake, serving multiple purposes including nutrition delivery and medication administration.
Lena Alodat, Wejdan Shahin, Lina Breik, Ayman Allahham   +3 more
wiley   +1 more source

Early in‐hospital treatment of acute heart failure. Part 2 of the international expert opinion series on AHF management

ESC Heart Failure, Volume 12, Issue 6, Page 3826-3843, December 2025.
This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu, Andrew P. Ambrosy, Gad Cotter, Edimar A. Bocchi, Javed Butler, Ovidiu Chioncel, Beth Davison, Anastase Dzudie, Yonathan Freund, Marat Fudim, Sivadasanpillai Harikrishnan, Ivna G. Cunha, Alexandre Mebazaa, Robert J. Mentz, Òscar Miró, Siti E. Nauli, Mateo Pagnesi, Naoki Sato, Gianluigi Savarese, Karen Sliwa‐Hahnle, Yuhui Zhang, Jingmin Zhou, Jan Biegus   +22 more
wiley   +1 more source

Diagnosis and management of hyponatraemia: AGREEing the guidelines [PDF]

, 2015
Hyponatraemia is a common electrolyte disorder associated with significant complications and controversies regarding its optimal management. Clinical practice guidelines and consensus statements have attempted to provide clinicians with evidence-based ...
Maxwell, Alexander P
core   +1 more source

#2841 AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENT CHARACTERISTICS ASSOCIATED WITH BETTER RESPONSE TO TOLVAPTAN TREATMENT [PDF]

, 2023
Vasiliki Gkika, Eirini Evangelou, Dimitra Gkalitsiou, Paraskevi Liaveri, Michaela Louka, Angelos Drakopoulos, Eirini Tigka, Kyriaki Vasileiou, Mihail Tsagkatakis, George Tsirpanlis   +9 more
openalex   +1 more source